Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S254-S266
Open Access | Times Cited: 201

Showing 1-25 of 201 citing articles:

Epidemiology and management of gestational diabetes
Arianne Sweeting, Wesley Hannah, Helena Bäckman, et al.
The Lancet (2024) Vol. 404, Iss. 10448, pp. 175-192
Closed Access | Times Cited: 59
Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association
Jennifer Lewey, Theresa M. Beckie, Haywood L. Brown, et al.
Circulation (2024) Vol. 149, Iss. 7
Open Access | Times Cited: 42
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial
Katrien Benhalima, Kaat Beunen, Nancy Van Wilder, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 6, pp. 390-403
Closed Access | Times Cited: 35
Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy
Kim Boggess, Arielle Valint, Jerrie Refuerzo, et al.
JAMA (2023) Vol. 330, Iss. 22, pp. 2182-2182
Open Access | Times Cited: 31
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials
Paschalis Karakasis, Dimitrios Patoulias, Konstantinos Pamporis, et al.
Metabolism (2023) Vol. 149, pp. 155710-155710
Closed Access | Times Cited: 23
Drug Therapies for Diabetes
Roni Weinberg Sibony, Omri Segev, Saar Dor, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17147-17147
Open Access | Times Cited: 23
Randomized Trial of Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy in Pregnancy
Sarit Polsky, Elizabeth Buschur, Kathleen Dungan, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 8, pp. 547-555
Closed Access | Times Cited: 14
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Qiyuan Keith Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 14
Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes
Carmen Quirós, María Teresa Herrera, Judit Amigó, et al.
Diabetes Technology & Therapeutics (2024)
Closed Access | Times Cited: 13
Using metabolomics and proteomics to identify the potential urine biomarkers for prediction and diagnosis of gestational diabetes
Jie Yu, Jing Ren, Yaolin Ren, et al.
EBioMedicine (2024) Vol. 101, pp. 105008-105008
Open Access | Times Cited: 10
Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes
Marie‐France Hivert, Frédérique White, Catherine Allard, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1689-1695
Open Access | Times Cited: 10
Can System Inflammation Response Index or Systemic Immune Inflammation Index predict gestational diabetes mellitus in the first trimester? A prospective observational study
Esra Gülen Yıldız, Atakan Tanaçan, Gülcan Okutucu, et al.
International Journal of Gynecology & Obstetrics (2024) Vol. 166, Iss. 2, pp. 837-843
Closed Access | Times Cited: 9
Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia
Farah Aziz, Mohammad Fareed Khan, A. Moiz
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Current barriers to initiating insulin therapy in individuals with type 2 diabetes
Alba Galdón Sanz-Pastor, Alicia Justel Enríquez, Ana Sánchez Bao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
The Role of the Glycemic Index and Glycemic Load in the Dietary Approach of Gestational Diabetes Mellitus
Ioanna Mavroeidi, Aspasia Manta, Athina Asimakopoulou, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 399-399
Open Access | Times Cited: 8
Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial
Mohammad Mahfuzul Haque, Kathy Tannous, William H. Herman, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102610-102610
Open Access | Times Cited: 8
Use of Continuous Glucose Monitors in the Hospital: The Diabetes Technology Society Hospital Meeting Report 2023
Tiffany Tian, Rachel E. Aaron, Andrea M. Yeung, et al.
Journal of Diabetes Science and Technology (2023) Vol. 17, Iss. 5, pp. 1392-1418
Closed Access | Times Cited: 16
Diet and gut microbiome: impact of each factor and mutual interactions on prevention and treatment of type 2, type 1, and gestational diabetes
Davide Menafra, Mattia Proganò, N Tecce, et al.
Human Nutrition & Metabolism (2024) Vol. 38, pp. 200286-200286
Open Access | Times Cited: 7
Identification and validation of gestational diabetes subgroups by data-driven cluster analysis
Benedetta Salvatori, Silke Wegener, Grammata Kotzaeridi, et al.
Diabetologia (2024) Vol. 67, Iss. 8, pp. 1552-1566
Open Access | Times Cited: 6
AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes
Michael Pangrace, Sheri Dolan, Thomas Grace, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 1-a Suppl, pp. S1-S15
Closed Access | Times Cited: 5
Metabolic score for insulin resistance predicts major adverse cardiovascular event in premature coronary artery disease
Dachuan Guo, Chong Zhang, Mingyan Zhang, et al.
Aging (2024)
Open Access | Times Cited: 5
Efficacy of automated insulin delivery in pregnant women with type 1 diabetes: a meta-analysis and trial sequential analysis of randomized controlled trials
Tamara Teixeira, Amanda Godoi, Pedro Romeiro, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 7, pp. 831-840
Closed Access | Times Cited: 5
Metformin use in pregnancy: What about long‐term effects in offspring?
Johanne Holm Toft, Inger Økland
Acta Obstetricia Et Gynecologica Scandinavica (2024) Vol. 103, Iss. 7, pp. 1238-1241
Open Access | Times Cited: 5
Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial
Mengyu Lai, Jianrong Weng, Jiaying Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Evaluation of Recurrent Pregnancy Loss
Viviana de Assis, Claudio Schenone Giugni, Stephanie Ros
Obstetrics and Gynecology (2024)
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top